tirzepatide micro dose Microdosing: Keep Weight Off? Small just got more powerful:

Conclusion In our primary analysis, the risk of MOF was not significantly different between users of GLP-1 RA and DPP-4i

All you need is some sort of side effect that becomes apparent over time that would shift consumers attitudes about these drugs so dont get too excited

These drugs, which stimulate insulin release and reduce appetite, offer promising therapeutic options for managing blood sugar levels and supporting weight loss in individuals with these conditions

If side effects at 1.7 mg are significant, many providers recommend staying at this dose for an additional 4 weeks before attempting the final escalation to 2.4 mg